Chen, J., Li, J., Ran, L., Yang, J., & Xie, Y. (2025). ANXA2 in hepatocellular carcinoma: Orchestrating tumorigenesis, progression, and therapeutic resistance toward precision targeting. Journal of Translational Medicine, 23(1), 1. https://doi.org/10.1186/s12967-025-07177-9
Chicago Style (17th ed.) CitationChen, Junyu, Jianlin Li, Liuxin Ran, Jianbo Yang, and Yang Xie. "ANXA2 in Hepatocellular Carcinoma: Orchestrating Tumorigenesis, Progression, and Therapeutic Resistance Toward Precision Targeting." Journal of Translational Medicine 23, no. 1 (2025): 1. https://doi.org/10.1186/s12967-025-07177-9.
MLA (9th ed.) CitationChen, Junyu, et al. "ANXA2 in Hepatocellular Carcinoma: Orchestrating Tumorigenesis, Progression, and Therapeutic Resistance Toward Precision Targeting." Journal of Translational Medicine, vol. 23, no. 1, 2025, p. 1, https://doi.org/10.1186/s12967-025-07177-9.